Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Virbac : Availability of the quarterly financial information as of September 30, 2017

Posted on: 14 Nov 17

Availability of the quarterly financial information as of September 30, 2017

Public release - November 14th, 2017

The quarterly financial information as of September 30, 2017 is available:

·   on our website: under the section Investors - Financial reports - 2017,


·   on request, under legal and regulatory conditions.

In accordance with the amendments implemented by the French financial markets authority (AMF), this document presents:

·   significant operations and events of the period,

·   a description of the group financial standing,

·   the turnover distribution by segment.

NYSE Euronext - compartiment A - code ISIN: FR0000031577 / MNEMO: VIRP
Corporate Finance: tél. 33 4 92 08 71 32 - e-mail:
Virbac - Shaping the future of animal health

Virbac: Availability quarterly financial information Sept 30, 2017

This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Virbac via GlobeNewswire

Last updated on: 15/11/2017

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.